お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は消化器系の治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは消化器系の治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の消化器系の治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは消化器系の治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に消化器系の治療市場を分類しています。本研究に含まれる主な企業は：AbbVie、Allergan、Johnson & Johnson、Takeda、Novartis、Pfizer、Merck、F. Hoffmann-La Roche、Eli Lilly、AstraZeneca、Procter & Gamble、Tillotts Pharma、Takeda、GlaxoSmithKline、Amgen

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Oral
    Parenteral

用途別の市場セグメント：
    IBD
    Irritable Bowel Syndrome (IBS)

本レポートの詳細内容
世界の消化器系の治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、消化器系の治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の消化器系の治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の消化器系の治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、消化器系の治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

消化器系の治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：消化器系の治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：消化器系の治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章消化器系の治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：消化器系の治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：消化器系の治療の主要企業の概要を提供し、製品の説明と仕様、消化器系の治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
Market Analysis and Insights: Global Gastrointestinal Therapeutics Market
The global Gastrointestinal Therapeutics market is projected to grow from US$ 37010 million in 2024 to US$ 50460 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
Accounting for more than 80% of the total market shares, the IBD disease market segment dominated the market. IBD involves a group of autoimmune diseases such as Crohn's disease and ulcerative colitis and is expected to grow at a CAGR of more than 4.3% in the next few years.
Report Covers:
This report presents an overview of global market for Gastrointestinal Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Gastrointestinal Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Gastrointestinal Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Gastrointestinal Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Gastrointestinal Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Gastrointestinal Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AbbVie, Allergan, Johnson & Johnson, Takeda, Novartis, Pfizer, Merck, F. Hoffmann-La Roche and Eli Lilly, etc.
Market Segmentation
By Company
    AbbVie
    Allergan
    Johnson & Johnson
    Takeda
    Novartis
    Pfizer
    Merck
    F. Hoffmann-La Roche
    Eli Lilly
    AstraZeneca
    Procter & Gamble
    Tillotts Pharma
    Takeda
    GlaxoSmithKline
    Amgen

Segment by Type
    Oral
    Parenteral

Segment by Application
    IBD
    Irritable Bowel Syndrome (IBS)

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Gastrointestinal Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gastrointestinal Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Oral
    Table 3. Key Players of Parenteral
    Table 4. Global Gastrointestinal Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Gastrointestinal Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Gastrointestinal Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Gastrointestinal Therapeutics Market Share by Region (2019-2024)
    Table 8. Global Gastrointestinal Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Gastrointestinal Therapeutics Market Share by Region (2025-2030)
    Table 10. Gastrointestinal Therapeutics Market Trends
    Table 11. Gastrointestinal Therapeutics Market Drivers
    Table 12. Gastrointestinal Therapeutics Market Challenges
    Table 13. Gastrointestinal Therapeutics Market Restraints
    Table 14. Global Gastrointestinal Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Gastrointestinal Therapeutics Revenue Share by Players (2019-2024)
    Table 16. Global Top Gastrointestinal Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2023)
    Table 17. Global Gastrointestinal Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Gastrointestinal Therapeutics, Headquarters and Area Served
    Table 20. Global Key Players of Gastrointestinal Therapeutics, Product and Application
    Table 21. Global Key Players of Gastrointestinal Therapeutics, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gastrointestinal Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2019-2024)
    Table 25. Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2025-2030)
    Table 27. Global Gastrointestinal Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Gastrointestinal Therapeutics Revenue Share by Application (2019-2024)
    Table 29. Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Gastrointestinal Therapeutics Revenue Share by Application (2025-2030)
    Table 31. North America Gastrointestinal Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Gastrointestinal Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Gastrointestinal Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Gastrointestinal Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Gastrointestinal Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Gastrointestinal Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Gastrointestinal Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Gastrointestinal Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Gastrointestinal Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Gastrointestinal Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Gastrointestinal Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Gastrointestinal Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Gastrointestinal Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Gastrointestinal Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Gastrointestinal Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Gastrointestinal Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Gastrointestinal Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Gastrointestinal Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Gastrointestinal Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Gastrointestinal Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Gastrointestinal Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Gastrointestinal Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Gastrointestinal Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Gastrointestinal Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Gastrointestinal Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 63. AbbVie Company Details
    Table 64. AbbVie Business Overview
    Table 65. AbbVie Gastrointestinal Therapeutics Product
    Table 66. AbbVie Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 67. AbbVie Recent Developments
    Table 68. Allergan Company Details
    Table 69. Allergan Business Overview
    Table 70. Allergan Gastrointestinal Therapeutics Product
    Table 71. Allergan Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 72. Allergan Recent Developments
    Table 73. Johnson & Johnson Company Details
    Table 74. Johnson & Johnson Business Overview
    Table 75. Johnson & Johnson Gastrointestinal Therapeutics Product
    Table 76. Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 77. Johnson & Johnson Recent Developments
    Table 78. Takeda Company Details
    Table 79. Takeda Business Overview
    Table 80. Takeda Gastrointestinal Therapeutics Product
    Table 81. Takeda Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 82. Takeda Recent Developments
    Table 83. Novartis Company Details
    Table 84. Novartis Business Overview
    Table 85. Novartis Gastrointestinal Therapeutics Product
    Table 86. Novartis Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 87. Novartis Recent Developments
    Table 88. Pfizer Company Details
    Table 89. Pfizer Business Overview
    Table 90. Pfizer Gastrointestinal Therapeutics Product
    Table 91. Pfizer Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 92. Pfizer Recent Developments
    Table 93. Merck Company Details
    Table 94. Merck Business Overview
    Table 95. Merck Gastrointestinal Therapeutics Product
    Table 96. Merck Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 97. Merck Recent Developments
    Table 98. F. Hoffmann-La Roche Company Details
    Table 99. F. Hoffmann-La Roche Business Overview
    Table 100. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product
    Table 101. F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 102. F. Hoffmann-La Roche Recent Developments
    Table 103. Eli Lilly Company Details
    Table 104. Eli Lilly Business Overview
    Table 105. Eli Lilly Gastrointestinal Therapeutics Product
    Table 106. Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 107. Eli Lilly Recent Developments
    Table 108. AstraZeneca Company Details
    Table 109. AstraZeneca Business Overview
    Table 110. AstraZeneca Gastrointestinal Therapeutics Product
    Table 111. AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 112. AstraZeneca Recent Developments
    Table 113. Procter & Gamble Company Details
    Table 114. Procter & Gamble Business Overview
    Table 115. Procter & Gamble Gastrointestinal Therapeutics Product
    Table 116. Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 117. Procter & Gamble Recent Developments
    Table 118. Tillotts Pharma Company Details
    Table 119. Tillotts Pharma Business Overview
    Table 120. Tillotts Pharma Gastrointestinal Therapeutics Product
    Table 121. Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 122. Tillotts Pharma Recent Developments
    Table 123. Takeda Company Details
    Table 124. Takeda Business Overview
    Table 125. Takeda Gastrointestinal Therapeutics Product
    Table 126. Takeda Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 127. Takeda Recent Developments
    Table 128. GlaxoSmithKline Company Details
    Table 129. GlaxoSmithKline Business Overview
    Table 130. GlaxoSmithKline Gastrointestinal Therapeutics Product
    Table 131. GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 132. GlaxoSmithKline Recent Developments
    Table 133. Amgen Company Details
    Table 134. Amgen Business Overview
    Table 135. Amgen Gastrointestinal Therapeutics Product
    Table 136. Amgen Revenue in Gastrointestinal Therapeutics Business (2019-2024) & (US$ Million)
    Table 137. Amgen Recent Developments
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Gastrointestinal Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Oral Features
    Figure 4. Parenteral Features
    Figure 5. Global Gastrointestinal Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Gastrointestinal Therapeutics Market Share by Application: 2023 VS 2030
    Figure 7. IBD Case Studies
    Figure 8. Irritable Bowel Syndrome (IBS) Case Studies
    Figure 9. Gastrointestinal Therapeutics Report Years Considered
    Figure 10. Global Gastrointestinal Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Gastrointestinal Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Gastrointestinal Therapeutics Market Share by Region: 2023 VS 2030
    Figure 13. Global Gastrointestinal Therapeutics Market Share by Players in 2023
    Figure 14. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2023
    Figure 16. North America Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Gastrointestinal Therapeutics Market Share by Type (2019-2030)
    Figure 18. North America Gastrointestinal Therapeutics Market Share by Application (2019-2030)
    Figure 19. North America Gastrointestinal Therapeutics Market Share by Country (2019-2030)
    Figure 20. United States Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Gastrointestinal Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Gastrointestinal Therapeutics Market Share by Type (2019-2030)
    Figure 24. Europe Gastrointestinal Therapeutics Market Share by Application (2019-2030)
    Figure 25. Europe Gastrointestinal Therapeutics Market Share by Country (2019-2030)
    Figure 26. Germany Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. China Gastrointestinal Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 33. China Gastrointestinal Therapeutics Market Share by Type (2019-2030)
    Figure 34. China Gastrointestinal Therapeutics Market Share by Application (2019-2030)
    Figure 35. Asia Gastrointestinal Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. Asia Gastrointestinal Therapeutics Market Share by Type (2019-2030)
    Figure 37. Asia Gastrointestinal Therapeutics Market Share by Application (2019-2030)
    Figure 38. Asia Gastrointestinal Therapeutics Market Share by Region (2019-2030)
    Figure 39. Japan Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. South Korea Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Southeast Asia Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. India Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Australia Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Market Share by Type (2019-2030)
    Figure 47. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Market Share by Application (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Gastrointestinal Therapeutics Market Share by Country (2019-2030)
    Figure 49. Brazil Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Mexico Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Turkey Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Israel Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. GCC Countries Gastrointestinal Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 56. Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 58. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 59. Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 60. Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 61. Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 62. F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 63. Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 64. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 65. Procter & Gamble Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 66. Tillotts Pharma Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 67. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 68. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 69. Amgen Revenue Growth Rate in Gastrointestinal Therapeutics Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed